1
|
Klingspor L, Ullberg M, Rydberg J, Kondori N, Serrander L, Swanberg J, Nilsson K, Jendle Bengtén C, Johansson M, Granlund M, Törnqvist E, Nyberg A, Kindlund K, Ygge M, Kartout-Boukdir D, Toepfer M, Hålldin E, Kahlmeter G, Özenci V. Epidemiology of fungaemia in Sweden: A nationwide retrospective observational survey. Mycoses 2018; 61:777-785. [PMID: 29920785 DOI: 10.1111/myc.12816] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2018] [Revised: 05/31/2018] [Accepted: 06/13/2018] [Indexed: 02/06/2023]
Abstract
OBJECTIVES To identify the epidemiology and antifungal susceptibilities of Candida spp. among blood culture isolates to identify the epidemiology and antifungal susceptibilities of Candida spp. among blood culture isolates in Sweden. METHODS The study was a retrospective, observational nationwide laboratory-based surveillance for fungaemia and fungal meningitis and was conducted from September 2015 to August 2016. RESULTS In total, 488 Candida blood culture isolates were obtained from 471 patients (58% males). Compared to our previous study, the incidence of candidaemia has increased from 4.2/100 000 (2005-2006) to 4.7/100 000 population/year (2015-2016). The three most common Candida spp. isolated from blood cultures were Candida albicans (54.7%), Candida glabrata (19.7%) and species in the Candida parapsilosis complex (9.4%). Candida resistance to fluconazole was 2% in C. albicans and between 0% and 100%, in non-albicans species other than C. glabrata and C. krusei. Resistance to voriconazole was rare, except for C. glabrata, C. krusei and C. tropicalis. Resistance to anidulafungin was 3.8% while no Candida isolate was resistant to amphotericin B. CONCLUSIONS We report an overall increase in candidaemia but a minor decrease of C. albicans while C. glabrata and C. parapsilosis remain constant over this 10-year period.
Collapse
Affiliation(s)
- Lena Klingspor
- Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Måns Ullberg
- Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.,Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
| | - Johan Rydberg
- Division of Laboratory Medicine, Department of Clinical Microbiology, Lund, Sweden
| | - Nahid Kondori
- Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - Lena Serrander
- Department Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
| | - Jonas Swanberg
- Department of Clinical Microbiology, Ryhov Hospital, Jönköping, Sweden
| | - Kenneth Nilsson
- Department of Medical Sciences, Section of Clinical Microbiology and Infectious Diseases, Uppsala University, Uppsala, Sweden
| | | | - Marcus Johansson
- Department of Clinical Microbiology, Kalmar County Hospital, Kalmar, Sweden
| | | | - Eva Törnqvist
- Department of Laboratory Medicine/Clinical Microbiology, Örebro University Hospital, Örebro, Sweden
| | - Anders Nyberg
- Laboratory Medicine/Clinical Microbiology, County Hospital Sundsvall-Härnösand, Sundsvall-Härnösand, Sweden
| | - Karin Kindlund
- Department of Clinical Microbiology, Hallands Hospital, Halmstad, Sweden
| | | | | | - Michael Toepfer
- Unilabs AB, Clinical Microbiology, Skaraborg Hospital, Skövde, Sweden
| | - Eva Hålldin
- Clinical Microbiology, Västerås Hospital, Västerås, Sweden
| | - Gunnar Kahlmeter
- Department of Clinical Microbiology, Central Hospital, Växjö, Sweden
| | - Volkan Özenci
- Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.,Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
| |
Collapse
|